UA Cancer Center awarded $9.6 million for prevention agent studies

TUCSON, Ariz. – The University of Arizona Early Phase Chemoprevention Consortium led by UA Cancer Center researchers Sherry Chow, PhD, and David Alberts, MD, has been awarded funding by the National Cancer Institute to conduct early-phase clinical trials to evaluate the safety, clinical activity, and biological effects of novel cancer preventive agents. This five-year award will total up to $9.6 million.Continue reading

Opportunity Alert: ACA Program Helps You Submit SBIR STTR Grants

The Arizona Commerce Authority was awarded an $80,000 grant from the US Small Business Administration and has contributed $200,000 in matching funds and in-kind services to develop the PIII Playbook; a structured program of training and technical assistance to prepare Arizona’s small high-tech companies to compete more effectively for federal SBIR/STTR Phase I and II awards and ultimately commercialize their innovations in Phase III.

Continue reading

ABRAXANE® Demonstrates Significant Improvement in Progression-Free Survival Compared to Standard Chemotherapy in Advanced Melanoma Patients

Society for Melanoma Research Abstracts Published Online in Organization’s JournalContinue reading

Dr. Robert Penny Honored by College of American Pathologists

The College of American Pathologists recently awarded Dr. Robert Penny the 2012 Distinguished Patient Care Award at its annual meeting.  Dr. Penny was recognized for his extensive scientific translational research to accelerate the adoption of molecular pathways and associated therapies into the field of pathology and oncology to improve the lives of cancer patients.Continue reading